Comparison between zoledronic acid and clodronate in the treatment of prostate cancer patients with bone metastases

Zoledronic acid to prevent bone loss in Chinese men receiving androgen deprivation therapy for prostate cancer

(2011) Chi-hang YEE et al.   Asia-Pacific Journal of Clinical Oncology

Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study

(2010) Nirmeen A. Sabry et al.   MEDICAL ONCOLOGY

Robotic radical prostatectomy in east Asia: development, surgical results and challenges

(2009) Sidney KH Yip et al.   CURRENT OPINION IN UROLOGY

Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials

(2009) David P Dearnaley et al.   LANCET ONCOLOGY

New research findings on zoledronic acid: Survival, pain, and anti-tumour effects

(2007) Fred Saad   CANCER TREATMENT REVIEWS

Bone Matters: Are Density Increases Necessary to Reduce Fracture Risk?

(2006) Kenneth G. Faulkner   JOURNAL OF BONE AND MINERAL RESEARCH